Journals / Akdeniz Tıp Dergisi / 2023 / Cilt: 9 - Sayı: 1

Retrospective analysis of clinical features in hospitalized COVID-19 cases in Alanya

Alanya’da yatarak tedavi gören COVID-19 hastalarının geriye dönük analizi

Pages
7–14
Publication Date
2023-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Being elderly, DM, dyspnea, profound lymphopenia, elevated d-dimer level, CRP being 20 times higher than the upper limit of normal, and high procalcitonin levels were statistically significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: COVID-19 pandemic caused by SARS-CoV-2 has resulted in serious morbidity and mortality around the world.
📊
Key Findings & Data:In this study, COVID-19 patients hospitalized in xxxx were examined.
💡
Conclusion & Impact:Being elderly, DM, dyspnea, profound lymphopenia, elevated d-dimer level, CRP being 20 times higher than the upper limit of normal, and high procalcitonin levels were statistically significant (p
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Koronavirüs · COVID-19 · SARS-COV-2

Abstract

Objective: COVID-19 pandemic caused by SARS-CoV-2 has resulted in serious morbidity and mortality around the world. In this study, COVID-19 patients hospitalized in xxxx were examined. Methods: A retrospective analysis was performed for COVID-19 patients hospitalized between March 2020 and May 2021. The definitive diagnosis was made by the detection of SARS-CoV-2 nucleic acid by RT-PCR. The demographic, clinic and laboratory values were obtained through the medical records. The degree of the illness was classified as mild, moderate, severe and critical. Results: Sixteen mild/moderate and 34 severe/critically ill patients were included. The mean age was 58±15.9 years, 64% being males. Hypertension (28%) and Diabetes mellitus (DM) (28%) were the most common comorbidities. Being elderly, DM, dyspnea, profound lymphopenia, elevated d-dimer level, CRP being 20 times higher than the upper limit of normal, and high procalcitonin levels were statistically significant (p

Özet

Amaç: SARS-CoV-2’nin etkeni olduğu COVID-19 pandemisi dünya genelinde ciddi morbidite ve mortaliteye neden olmaktadır. Bu çalışmada XXXXX’de yatarak takip ettiğimiz COVID-19 olguları geriye dönük irdelendi. Yöntemler: Mart 2020-Mayıs 2021tarihleri arasında COVID-19 tanısı ile yatırılarak takip ettiğimiz hastalar retrospektif olarak tarandı. Gerçek-zamanlı polimeraz zincir reaksiyonu (RT-PCR) ile SARS CoV-2 viral nükleik asit testi pozitif olan hastalar çalışmaya dahil edildi. Çalışmaya dahil edilen olguların hastane bilgi yönetim sistemi üzerindeki kayıtları ve dosyaları retrospektif olarak tarandı. Hastaların demografik, klinik ve laboratuvar değerleri hazırlanan formlara işlendi. Hastalığın derecesi hafif, orta, ciddi ve kritik olarak sınıflandırıldı. Bulgular: Onaltı hafif/orta, 34 ciddi/kritik hasta çalışmaya dahil edildi. Hastaların ortalama yaşı 58±15.9 yıl olup %64’ü erkek idi. Hipertansiyon (%28) ve Diabetes mellitus (DM) (%28) en sık saptanan komorbid hastalıklardı. Ciddi ve kritik hastalarda ileri yaş, DM, solunum sıkıntısı, derin lenfopeni (20 kat yüksekliği, prokalsitonin yüksekliği (>0.25ng/ml) istatiksel olarak (p

🔖

Cite This Article

ERDOĞAN, A., ERDOĞAN, H. (2023). Retrospective analysis of clinical features in hospitalized COVID-19 cases in Alanya. Akdeniz Tıp Dergisi, Cilt: 9 - Sayı: 1, 7–14. https://ajindex.com/articles/866499

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Alp Ş, Ünal S. Yeni koronavirüs (SARS-CoV-2) kaynaklı pandemic: Gelişmeler ve güncel durum. FLORA 2020; 25 (28 Mayıs 2020)
  2. Erensoy S. COVID-19 pandemisinde SARS-CoV-2 ve mikrobiyolojik tanı dinamikleri. Mikrobiyol Bul 2020;54(3):497-509 3- Karakoç ZÇ, Pınarbaşı-Şimşek B, Asil R, et al. First wave in COVİD-19 pandemic: A single center experience. Klimik Derg 2020; 33(3):223-9.4 4-TC Sağlık Bakanlığı COVID-19 bilgilendirme sayfası. 1 Şubat 2021
  3. WHO. 6 Şubat 2021
  4. CDC: Emerging SARS-CoV-2 Variants. Update January, 28, 2021. 6 Şubat 2021.
  5. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020[J]. China CDC Weekly, 2020, 2(8): 113-122
  6. NIH COVID-19 treatment guidelines. 6 Şubat 2021
  7. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. 6 Şubat 2021
  8. TC Sağlık Bakanlığı COVID-19 rehberi. 6 Şubat 2021.
  9. European Centre for Disease Prevention and Control, case definition for coronavirus disease 2019 (COVID-19). 6 Şubat 2021.
  10. Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021; 65: 101205
  11. Mukherjee S, Pahan K. Is COVID-19 Gender-sensitive? Journal of Neuroimmune Pharmacology (
  12. Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 Oct 23;370(6515):eabd4585
  13. Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2020;14:535–545
  14. Zhu L, She Z, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing